Company intelligence / Profile preview

Crinos

Villa Guardia, Lombardy, Italycrinos.it ↗
Ownership
Private
Development stage
Other
01

Overview

Crinos is an Italian pharmaceutical company founded in 1944, specializing in the research, development, and commercialization of treatments for cardiovascular and metabolic diseases. The company is historically significant for discovering and developing sulodexide and defibrotide, two complex biological drugs used globally for vascular and hematological conditions. In 1996, Crinos was acquired by Mediolanum Farmaceutici, under which it continues to operate as a prominent brand in the Italian healthcare market. Its current portfolio focuses on vascular health, gastroenterology, and specialized primary care products. The company maintains a strong presence in Italy while its legacy products are distributed internationally through various licensing partnerships.

Therapeutic areas
HematologyCardiovascularNephrology
Modalities
BiologicSmall molecule
Industry
Biotech
02

Partnerships

GentiumJazz PharmaceuticalsAlfasigma

Beyond the preview

Go deeper on Crinos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crinos.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call